Theophylline kinetics in acute pulmonary edema
- PMID: 837650
- DOI: 10.1002/cpt1977213310
Theophylline kinetics in acute pulmonary edema
Abstract
Nine patients with acute cardiogenic pulmonary edema were given theophylline intravenously, and its disposition was observed over the next 24 hr. Compared to that in 19 normal subjects, these patients had prolonged plasma half-lifes (mean, 22.9 from 6.7 hr) and decreased plasma clearances of theophylline (mean, 0.041 from 0.062 L [kg-1] hr-1). The intersubject variation in these parameters was 20-fold in patients with pulmonary edema and 4-fold in normal subjects. Since the peak plasma concentrations attained and the apparent volumes of distribution were not different in the two groups, a suitable initial dose can be calculated. A loading dose of 4.5 to 5 mg/kg theophylline (6 mg/kg aminophylline) given over 20 min appears safe. Because of the great variability in the plasma clearance of this drug in patients with heart failure, plasma concentrations and toxicity would be unpredictable after repeated doses or constant infusions.
Similar articles
-
Kinetics of theophylline; variability and effect of arterial pH in chronic obstructive lung disease.Chest. 1979 Jul;76(1):11-6. doi: 10.1378/chest.76.1.11. Chest. 1979. PMID: 36261
-
Kinetics of intravenous theophylline.Clin Pharmacol Ther. 1977 Aug;22(2):188-95. doi: 10.1002/cpt1977222188. Clin Pharmacol Ther. 1977. PMID: 884920
-
Apparent theophylline half-life fluctuations during treatment of acute left ventricular failure.Am J Hosp Pharm. 1977 Apr;34(4):408-9. Am J Hosp Pharm. 1977. PMID: 860722
-
Clinical pharmacology. Series on pharmacology in practice. 4. Theophylline. Practical application of new knowledge.Mayo Clin Proc. 1979 Nov;54(11):733-45. Mayo Clin Proc. 1979. PMID: 386000 Review. No abstract available.
-
Effect of disease states on theophylline serum concentrations: are we still vigilant?Am J Med Sci. 2000 Mar;319(3):177-82. doi: 10.1097/00000441-200003000-00007. Am J Med Sci. 2000. PMID: 10746828 Review.
Cited by
-
The pharmacokinetics of theophylline and enprofylline in patients with liver cirrhosis and in patients with chronic renal disease.Eur J Clin Pharmacol. 1988;35(4):357-62. doi: 10.1007/BF00561364. Eur J Clin Pharmacol. 1988. PMID: 3197743
-
Aging, cigarette smoking and oral theophylline requirement.Eur J Clin Pharmacol. 1981;21(1):33-7. doi: 10.1007/BF00609585. Eur J Clin Pharmacol. 1981. PMID: 7333344
-
Serum level monitoring of a new slow release theophylline formulation in patients with chronic lung disease.Br J Clin Pharmacol. 1980 Sep;10(3):265-71. doi: 10.1111/j.1365-2125.1980.tb01754.x. Br J Clin Pharmacol. 1980. PMID: 7437244 Free PMC article.
-
The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients.Clin Pharmacokinet. 1988 Jun;14(6):347-73. doi: 10.2165/00003088-198814060-00003. Clin Pharmacokinet. 1988. PMID: 3293870 Review.
-
Differential pharmacokinetics of theophylline in elderly patients.Drugs Aging. 2003;20(1):71-84. doi: 10.2165/00002512-200320010-00005. Drugs Aging. 2003. PMID: 12513116 Review.